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Obesity is associated with glomerular hyperfiltration and
increased urinary protein excretion, as well as structural and
functional changes that lead to kidney disease and failure.
Dietary protein mimics obesity’s effects on the glomerular
filtration rate (GFR) and proteinuria and, in certain
circumstances, may have the potential to adversely affect
kidney function. Here we tested the hypothesis that dietary
protein independently explains elevations in the GFR and
proteinuria found in obese persons with a normal serum
creatinine. Seventeen patients were randomized in a
double-blind, crossover fashion for 1-week periods to high
(140g/day) and low (50g/day) protein diets with a 1-week
washout interval separating these periods. High protein
consumption was associated with a very modest but
significant increase in the GFR of 5±6ml/min. Hence,
while dietary protein does modulate kidney parameters,
it is unlikely to fully account for the elevations in GFR
and proteinuria found in obesity.
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The World Health Organization projects that by 2015
approximately 2.3 billion adults will be overweight and
more than 700 million obese (http://www.who.int/mediacentre/
factsheets/fs311/en/index.html). The obesity public health crisis
has profound implications for the field of kidney disease.
Obesity is associated with glomerular hyperfiltration, increased
urinary protein excretion, and structural and functional
changes that can lead to kidney disease and failure.1–10 Indeed,
up to one-third of kidney disease in the United States has been
directly attributed to obesity.11
Kidney-related studies in obese humans have thus far focused
primarily on the effects of excess adiposity as the principal cause
of kidney dysfunction, downplaying the potential influence of
diet. Yet it is well established that dietary protein mimics
obesity’s effects on the glomerular filtration rate (GFR) and
proteinuria and, in certain circumstances, may have the potential
to adversely affect kidney function.12–15 This is important
because, not surprisingly, obese individuals consume more
dietary protein than do lean persons.16 With rare exception,17
neither the experimental nor epidemiological reports3,5,7–9,18
account for the potentially important influence of protein intake.
Designing effective strategies to prevent and manage
obesity-related kidney disease requires a fundamental under-
standing of the independent effects of dietary protein on the
kidney. We therefore designed an experiment to test the
hypothesis that dietary protein explains obesity-associated
elevations in GFR and proteinuria independent of weight.
RESULTS
Baseline characteristics for the 17 subjects who completed the
dietary intervention study are shown in Table 1. The majority
of subjects were white women with normal kidney indices.
Effects on kidney parameters are described in Table 2.
Serum blood urea nitrogen, 24 h urine urea excretion, and
estimated protein consumption were markedly higher on the
high-protein diet whereas weight remained stable. High
protein consumption was associated with a modest increase
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in GFR (Figure 1) whereas serum creatinine and cystatin C
levels remained virtually unchanged. Effects on urinary
protein excretion were mixed, with total urinary protein
increasing but urinary albumin falling, though neither to a
statistically significant extent. Blood pressure and glycemic/
insulin markers were unchanged.
DISCUSSION
Our experiments are the first to elucidate the independent
influence of dietary protein on kidney parameters in obese
individuals. On the basis of our findings, it is unlikely that
dietary protein intake alone explains the impressive elevations in
GFR and proteinuria observed in many obese individuals.
Table 1 | Baseline characteristics in dietary intervention
All subjects LP-HPa HP-LPa
Number of patients 17 8 9
Age (years) 45±10 48±8 42±11
Female, N (%) 15 (88) 7 (88) 8 (89)
Race
White, N (%) 13 (76) 6 (75) 7 (78)
Black, N (%) 4 (24) 2 (25) 2 (22)
Weight (kg) 121±30 121±40 122±19
Height (m) 1.67±0.10 1.68±0.11 1.65±0.09
BMI (kg/m2) 43.6±9.2 41.9±9.9 45.0±8.8
Systolic blood pressure (mmHg) 134±14 140±14 130±12
Diastolic blood pressure (mmHg) 80±11 84±10 76±12
Serum creatinine (mg/dl) 0.74±0.13 0.77±0.10 0.71±0.15
Cystatin C (mg/l) 0.84±0.15 0.88±0.20 0.81±0.11
24 h urinary albumin excretion (mg)b 9.5 (3.3, 174.7) 10.2 (3.3, 174.7) 7.5 (4.0, 23.8)
Fasting glucose (mg/dl) 88±13 89±15 87±11
HOMA scoreb 4.0 (0.7, 18.0) 3.7 (0.7, 18.0) 4.1 (2.9, 7.2)
Abbreviations: BMI, body mass index; HOMA, homeostasis model assessment; HP, high protein; LP, low protein.
Mean±s.d., unless otherwise specified.
aLP-HP: randomized to low-protein then high-protein dietary protocol; HP-LP: randomized to high-protein then low-protein dietary protocol.
bMedian (range).
Table 2 | Effects of dietary protein intervention on kidney and metabolic parameters
HPa LPa Differenceb P-valuec
N 17 17 — —
Weight (kg) 120±29 120±29 0±2 0.977
Dietary protein intake (g/day) 99±23 50±14 49±24 o0.001
GFR (ml/min) 114±25 109±26 5±6 0.005
Serum creatinine (mg/dl) 0.75±0.14 0.76±0.16 0.01±0.09 0.580
Serum cystatin C (mg/l) 0.83±0.16 0.86±0.20 0.03±0.10 0.270
24 h urine protein (mg/day) 188±73 173±84 15±88 0.538
24 h urine albumin (mg/day)d 9 (3,30) 11 (3,59) 1 (51, 16) 0.147
24 h urine urea (g/day) 13.8±3.5 6.0±2.1 7.8±3.9 o0.001
24 h urine creatinine (g/day) 1.6±0.4 1.6±0.6 0.1±0.4 0.533
BUN (mg/dl) 14±4 7±3 7±4 o0.001
Systolic blood pressure (mmHg) 128±13 128±11 0±11 0.872
Diastolic blood pressure (mmHg) 74±9 74±7 0±7 0.962
Fasting glucose (mg/dl) 89±17 90±9 1±12 0.809
HOMA scored 3.9 (1.3, 13.3) 4.0 (0.8, 10.3) 0.3 (2.6, 9.7) 0.435
Abbreviations: BUN, blood urea nitrogen; GFR, glomerular filtration rate; HOMA, homeostasis model assessment; HP, high protein; LP, low protein.
aEnd point measurements on high-protein and low-protein diets.
bMean±s.d.
cPaired t-test.
dMedian (range).
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Figure 1 | Effect of protein consumption on GFR. P¼ 0.005 for
difference. GFR, glomerular filtration rate; HP, high protein;
LP, low protein.
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A large body of literature shows that both dietary protein
ingestion and obesity are associated with increases in GFR
and urinary protein and albumin excretion.2,19,20 What has
not been directly addressed is whether alterations of kidney
parameters in obese individuals are entirely explainable by
higher protein consumption,16 an issue with important
clinical implications. Our obese cohort manifested a wide
range of baseline GFR that rose on average only modestly
(5ml/min) after consuming a high-protein diet. Neither was
a more dramatic rise observed in the heavier subgroup of
subjects that later underwent bariatric surgery. Directly
measured GFR in severely obese individuals is commonly
observed to be much higher than 120ml/min, occasionally
approaching 200ml/min.10,21–24 It is therefore unlikely that
higher protein consumption by itself explains the glomerular
‘hyperfiltration’ of obesity, both because of the lack of
absolute hyperfiltration observed in the majority of study
subjects while consuming the high-protein diet and the
relatively minor effect that such a diet had on GFR. Nor,
given the modest changes we observed, is it likely to explain
obesity-associated proteinuria.2,19,25 Although one can pos-
tulate that perhaps this is because obese individuals consume
more dietary protein than they were fed in our study, this is
not supported by our baseline urinary measurements. In fact,
our findings are generally consistent with previous observa-
tions in lean subjects.26 They also support the contention
derived from animal studies that total caloric intake and
subsequent weight gain, rather than any particular dietary
constituent, is the major promoter of obesity-related
changes.6,27 We cannot exclude the possibility that modest
effects of dietary protein on proteinuria were simply
subsumed by more noticeable effects related to obesity. The
lack of a large increase in either GFR or proteinuria after the
short-term high-protein diet is consistent with longer-term
epidemiological evidence showing that high protein con-
sumption is not associated with kidney disease in lean
populations with normal kidney function.15,28
One limitation of this study was its size, though it did not
prevent us from detecting relatively small differences in GFR
between diets. Bariatric and other very obese patients are, for
obvious reasons, a challenging population to study in diet-
based protocols. In addition, the study was performed in
nondiabetic, mostly female obese adults without overt kidney
disease, so its conclusions may not necessarily be general-
izable to other population (though there are no reports of sex
differences in the kidney’s response to dietary protein or
weight loss). The short-term nature of the study may also
limit generalizability. Further distinguishing between the
separate effects of dietary protein and adiposity on kidney
health can be achieved by repeating the dietary interventions
we undertook within individuals before and after significant
weight loss. Because weight loss is very difficult to achieve,
this approach would seem to be unfeasible. However,
available surgical interventions can achieve excellent weight
loss results that cannot be matched by dietary regimens. We
propose that such models be used to address this issue. In
fact, we have begun such a study in bariatric surgery patients,
which we believe will extend our current findings.
Interestingly, the study shows the relative insensitivity of
endogenous clearance markers serum cystatin C and creati-
nine to changes in GFR in severely obese individuals with
putatively normal renal function, supporting our previous
findings.24 GFR-estimating equations and other strategies
specifically derived and validated in obese populations may
improve our ability to estimate GFR in such subjects.
In conclusion, although dietary protein modestly influ-
ences kidney function, it is unlikely to fully explain obesity-
related elevations in GFR and proteinuria observed in obese
individuals. Efforts to better understand how and why
obesity influences kidney function using human models, as
well as how to best measure and estimate kidney function in
obese populations, should be encouraged.
PARTICIPANTS AND METHODS
Study population
Obese individuals were recruited from bariatric surgery clinics and
public advertisements in the Indianapolis, Indiana, area between
April 2004 and October 2007. The relevant institutional review
boards approved the protocol (NCT00244790), and all patients gave
written informed consent after reviewing a written summary of the
plan. A data safety and monitoring board oversaw the study.
Inclusion criteria included age 18 or greater and body mass index of
30 kg/m2 or higher. Exclusion criteria included pregnancy, an iodine
allergy, diabetes mellitus, use of an angiotensin-converting enzyme
inhibitor or angiotensin receptor blocker, and a serum creatinine
41.3mg/dl for women and 41.5mg/dl for men. Pregnancy was
excluded by a urine pregnancy test on the study day.
Dietary protein intervention
This randomized, double-blind, crossover dietary study in obese
subjects was designed to measure the independent effect of protein
consumption on GFR and proteinuria, the two main markers
of kidney function and disease,29 when weight was held constant.
A computer-generated random diet sequence assigned subjects to
one of the two protocols. Protocol 1 involved a 1-week high-protein
diet, followed by a 1-week washout period, followed by 1-week
low-protein diet. Protocol 2 was the reverse. The washout period
was sufficiently long to avoid carryover effect based on previous
experience.30 End point measurements were performed immediately
before and after each dietary study period for a total of four studies
per subject. Subjects and investigators were masked to the protein
diet. An Indiana University General Clinical Research Center
dietitian using the University of Minnesota’s Nutrition Data System
for Research nutrient calculation software (http://www.ncc.umn.edu/)
developed the study diet while tailoring it as much as possible to the
subject’s dietary tastes. Meals were prepared and frozen in disposable
containers that could subsequently be microwaved or heated in
ovens at home. Subjects were carefully instructed to limit their
dietary intake during the study period to study meals only and
return any unfinished meals at the end of the study week. Dieticians
contacted subjects by phone during the study intervention period to
assess dietary compliance and help resolve any diet-related concerns.
They also estimated dietary nonadherence by quantifying any
unfinished meals and performing a 24 h dietary recall interview.
Low- and high-protein-diet meals contained 50 and 140 g protein
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daily, respectively, and all meals contained 4 g sodium daily and were
isocaloric (30–35 kcal/kg/day) to maintain a steady weight during
the study period. Dietary protein intake (in g/day) was estimated by
24 h urinary urea excretion.31
Measurements
Glomerular filtration rate was calculated from plasma iohexol
(Omnipaque-300; GE Healthcare, Piscataway, NJ, USA) clearance.
Plasma was isolated and stored at 80 1C until measured by
capillary electrophoresis using a Model 2050 CE instrument
(Beckman Instruments, Palo Alto, CA, USA) by injecting the serum
directly on untreated capillary followed by separation based on
micellar electrokinetic chromatography.32 Individual iohexol clear-
ances (ml/min) were estimated using population pharmacokinetic
methods as previously described.24
Cystatin C was measured using particle-enhanced immunone-
phelometry (Siemens/Dade Behring BN II Nephelometer, Deerfield,
IL, USA), and serum creatinine by the Roche/Hitachi Creatinine
Plus enzymatic assay (Roche Diagnostics, Basel, Switzerland).
24 h urine protein, albumin, creatinine, urea and calcium levels,
and serum blood urea nitrogen were measured using standard
laboratory techniques. Body mass index and body surface area33
were calculated during each visit from measured weight and
height while wearing a hospital gown and no shoes. Two blood
pressure measurements were taken while seated separated by a
5-min interval and then averaged. Body composition was measured
using bioelectrical impedance analysis (BIA-101Q Fluid/Nutrition
Bio-Electrical Impedance Analyzer System with Cyprus 1.0 Body
Composition Analysis software; RJL Systems, Clinton Township, MI,
USA).34 The homeostasis model assessment score was calculated to
estimate insulin resistance.35
Statistical methods
The study’s main aim was to determine the dietary protein intake effect
on GFR level and proteinuria in obese humans independent of weight.
Subject demographic information and baseline characteristics were
summarized by mean±s.d. or frequency for continuous variables and
categorical variables, respectively. With a complete randomized diet
sequence assignment at baseline, the effect of dietary protein was
evaluated by comparing the post-diet measurements after high-protein
and after low-protein diet using paired t-tests. Normality assumptions
were examined, and rank-based tests were used if there was a normality
assumption violation. Scatter plots were used to illustrate the
distribution of GFR for the two diet plans. All statistical tests were
performed at a two-sided 5% significant level using SAS 9.1 software
package (SAS Inc., Cary, NC, USA).
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